Addus HomeCare

Aging Population Trends And Technology Will Expand Home Care

AnalystHighTarget

Not Invested

Consensus Narrative from 11 Analysts

Published

04 May 25

Updated

20 Aug 25

AnalystHighTarget's Fair Value

US$160.00

26.0% undervalued

20 Aug

US$118.41

-11.0%

3.7%

Author's Valuation

US$160.0

26.0% undervalued

AnalystHighTarget Fair Value

Narrative

Updates1

Shared on07 May 25

AnalystHighTarget Fair Value

US$160.0

26.0% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

9.31%

Healthcare Services revenue growth rate

0.26%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.78%

Calculation

US$144.05m

Earnings '28

24.34x

PE Ratio '28

US$3.51b

Market Cap '28

US$3.51b

Market Cap '28

18.87m

No. shares '28

US$185.75

Share Price '28

US$185.75 Share Price '28

Discounted to 2025 @ 6.78% p.a.

US$152.59

Fair Value '25